GLP-1 Drugs, Obesity & Surgical Infection Risk What the 2026 Evidence Means for IPC HOSPITAL INFECTION CONTROL TIP OF THE DAY 027 GLP-1 Drugs, Obesity & Surgical Infection Risk What the 2026 Evidence Means for IPC 1 WHY IT MATTERS 2026 is the year GLP-1 receptor agonists went mainstream globally oral semaglutide approved by FDA in December 2025, tirzepatide expanding indications, Indian patent expiries imminent, and one in eight adults now on a GLP-1 medication in some markets
Angew Chem Int Ed
Allergen information Produced in a facility that may process allergens such as gluten, soy, egg, and nuts
The scores range from 0 to 100, with higher scores indicating fewer symptoms phy, physical limitations and body weight change
Yes, many travellers choose to have a B12 injection before a summer holiday in the North West if they are experiencing symptoms of low energy or vitamin B12 deficiency
Stay active to improve metabolism and overall well-being